Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapy.
Journal: European urology focus
Published: February 27, 2026
Initial experience with aspirin use during robotic radical prostatectomy.
Journal: Journal of laparoendoscopic & advanced surgical techniques. Part A
Published: March 08, 2012
Showing 1-2 of 2
Last Updated: 09/26/2026